(1.20%) 5 070.55 points
(0.69%) 38 504 points
(1.59%) 15 697 points
(0.12%) $83.46
(1.21%) $1.834
(-0.26%) $2 336.10
(-0.26%) $27.29
(-0.04%) $922.40
(-0.04%) $0.934
(-0.01%) $10.90
(-0.03%) $0.803
(0.00%) $93.19
Live Chart Being Loaded With Signals
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases...
Stats | |
---|---|
Today's Volume | 96 855.00 |
Average Volume | 393 619 |
Market Cap | 59.77M |
EPS | $0 ( 2024-03-12 ) |
Next earnings date | ( $-0.190 ) 2024-05-02 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.610 |
ATR14 | $0.0110 (1.31%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-01 | Mcclure Matthew W. | Buy | 72 000 | Stock Option (Right to Buy) |
2024-03-01 | Calhoun Lesley Ann | Buy | 308 940 | Stock Option (Right to Buy) |
2024-03-01 | Symons Julian A. | Buy | 72 000 | Stock Option (Right to Buy) |
2024-03-01 | Blatt Lawrence | Buy | 965 435 | Stock Option (Right to Buy) |
2024-02-28 | Hirth Peter | Buy | 4 411 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
82.23 |
Last 96 transactions |
Buy: 18 924 669 | Sell: 1 675 487 |
Volume Correlation
Aligos Therapeutics, Inc. Correlation
10 Most Positive Correlations | |
---|---|
MCRB | 0.914 |
EIGR | 0.914 |
SPRC | 0.908 |
BTTX | 0.907 |
ENTA | 0.907 |
CYN | 0.906 |
AFIB | 0.906 |
CAMP | 0.905 |
GOCO | 0.904 |
MESA | 0.904 |
10 Most Negative Correlations | |
---|---|
GEEX | -0.92 |
FXCO | -0.918 |
LDHA | -0.917 |
NESR | -0.914 |
TCVA | -0.911 |
ALOR | -0.911 |
TBSA | -0.909 |
VLAT | -0.909 |
AHRN | -0.908 |
LGAC | -0.908 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Aligos Therapeutics, Inc. Correlation - Currency/Commodity
Aligos Therapeutics, Inc. Financials
Annual | 2023 |
Revenue: | $15.53M |
Gross Profit: | $12.46M (80.24 %) |
EPS: | $-1.360 |
Q4 | 2023 |
Revenue: | $2.68M |
Gross Profit: | $1.91M (71.09 %) |
EPS: | $-0.220 |
Q3 | 2023 |
Revenue: | $3.24M |
Gross Profit: | $2.56M (78.97 %) |
EPS: | $-0.410 |
Q2 | 2023 |
Revenue: | $6.89M |
Gross Profit: | $6.12M (88.83 %) |
EPS: | $-0.430 |
Financial Reports:
No articles found.
Aligos Therapeutics, Inc.
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB); and ALG-000184, a capsid assembly modulator, which is in Phase I clinical trials to treat CHB. The company also develops ALG-020572, an antisense oligonucleotide to prevent HBsAg translation and secretion; and ALG-055009, a small molecule THR-ß agonist that is in the Phase 1a/1b for the treatment of non-alcoholic steatohepatitis(NASH). In addition, it develops siRNA drug candidate, ALG-125755, as well as ALG-125097 and ALG-125819, demonstrated potent inhibition of HBsAg release from HBV-infected cells. It has entered into license and collaboration agreements with Luxna Biotech Co., Ltd. to develop and commercialize products containing oligonucleotides targeting hepatitis B virus genome; Emory University to provide hepatitis B virus capsid assembly modulator technology; research, licensing, and commercialization agreement with Katholieke Universiteit Leuven to develop coronavirus protease inhibitors; and Merck to discover, research, optimize, and develop oligonucleotides directed against a NASH. The company was incorporated in 2018 and is headquartered in South San Francisco, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators